TSE:4516Pharmaceuticals
Nippon Shinyaku (TSE:4516) Margin Compression Challenges Bullish Growth Narratives In Q3 2026
Nippon Shinyaku (TSE:4516) has reported a busy quarter, with Q3 2026 revenue of ¥47,488 million and basic EPS of ¥149.71, while its trailing twelve month figures are ¥166.0 billion in revenue and EPS of ¥443.18. The company’s revenue increased from ¥41,988 million in Q3 2025 to ¥47,488 million in Q3 2026, with basic EPS moving from ¥180.82 to ¥149.71 over the same period. This provides a clear context for how the top and bottom lines are tracking into this year. With a trailing net margin of...